Exelixis filed required disclosures regarding share holdings with the Securities and Exchange Commission.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Exelixis filed required disclosures regarding share holdings with the Securities and Exchange Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Exelixis
American biotechnology company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- USA Rare Earth disclosed stock activity to the Securities and Exchange Commission on October 8, 2026.
- Required filings have been made with the Securities and Exchange Commission regarding institutional investment disclosures due to increased holdings in the iShares S&P Mid-Cap 400 Value ETF.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.